{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:20:44Z","timestamp":1764566444240,"version":"3.46.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>B cells play a central role in multiple sclerosis (MS) pathogenesis, yet their activation profiles during the earliest disease stages remain incompletely characterized. We aimed to investigate the expression of the activation markers CD40 and CD71 across peripheral B cell subsets in individuals with radiologically isolated syndrome (RIS), and compare them to those with clinically isolated syndrome or MS (CIS\/MS) and healthy controls (HC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood cells from individuals with RIS (n=21), CIS\/MS (n=15), and HC (n=15) were analyzed by flow cytometry. CD40 and CD71 expression was assessed across major B cell subsets. Epstein-Barr virus (EBV) serologies were measured to explore associations with activation marker expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CD40 expression was reduced on transitional, na\u00efve, B cell subsets in RIS compared to CIS\/MS and HC (p&amp;lt;0.001). CD71 expression remained stable across groups. CD40 expression was preserved in plasmablasts and regulatory B cells. No significant associations were observed between CD40 levels and EBV antibody titers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this cross-sectional cohort, CD40 expression was lower on transitional, na\u00efve, and memory B cell subsets in RIS compared to CIS\/MS and HC, whereas plasmablasts and regulatory B cells were comparable. This pattern is consistent with an altered costimulatory state in early, asymptomatic disease and warrants longitudinal studies to determine its clinical relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1680233","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:52Z","timestamp":1764566212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Christian W.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreu","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa M.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"\u00c1lvarez-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Protopapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Fissolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Enrique","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Quiroga-Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Garc\u00eda-Sarre\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Midaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan D.","family":"L\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Comabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B cells in multiple sclerosis and related disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","article-title":"B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies","volume":"17","author":"Cencioni","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMc1702076","article-title":"Ocrelizumab in primary progressive and relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.01.010","article-title":"Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin","volume":"233","author":"Obermeier","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq350","article-title":"Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis","volume":"134","author":"Lovato","year":"2011","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63842","article-title":"B cell exchange across the blood-brain barrier in multiple sclerosis","volume":"122","author":"von B\u00fcdingen","year":"2012","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00201","article-title":"The role of B cells and antibodies in multiple sclerosis, neuromyelitis optica, and related disorders","volume":"10","author":"Hausser-Kinzel","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1615\/CritRevImmunol.v37.i2-6.100","article-title":"Functions of CD40 and its ligand, gp39 (CD40L)","volume":"37","author":"Laman","year":"2017","journal-title":"Crit Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2022.01.012","article-title":"CD40 signaling-mediated delay in terminal differentiation of B cells enables alternate fate choices during early divisions","volume":"144","author":"Vijayashankar","year":"2022","journal-title":"Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.6.2373-2386.2006","article-title":"Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis","volume":"26","author":"O\u2019Donnell","year":"2006","journal-title":"Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s42003-020-01294-5","article-title":"Transferrin receptor 1 is a cellular receptor for human heme-albumin","volume":"3","author":"Jennifer","year":"2020","journal-title":"Commun Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5603\/fhc.2012.0040","article-title":"Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia","volume":"50","author":"P\u0142oszy\u0144ska","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517717808","article-title":"Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations","volume":"24","author":"De Stefano","year":"2018","journal-title":"Mult Scler"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"EuroFlow PID group. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2018.77772","article-title":"Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor \u03b21 in human peripheral blood","volume":"15","author":"Karim","year":"2019","journal-title":"Arch Med Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26507","article-title":"Impaired B cell expression of the inhibitory fc\u03b3 Receptor IIB in myasthenia gravis","volume":"92","author":"Keller","year":"2022","journal-title":"Ann Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqae012","article-title":"The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs)","volume":"5","author":"Ahsan","year":"2024","journal-title":"Oxf Open Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900488","article-title":"CD24hiCD38hi and CD24hiCD27+ Human regulatory B cells display common and distinct functional characteristics","volume":"203","author":"Hasan","year":"2019","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2024.152854","article-title":"The role of CD24hiCD27+ regulatory B cells in human chronic rhinosinusitis with\/without nasal polyps","volume":"229","author":"Tian","year":"2024","journal-title":"Immunobiology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241274571","article-title":"Cytomegalovirus immune responses are associated with lower serum NfL and disability accumulation risk at multiple sclerosis onset","volume":"30","author":"L\u00fcnemann","year":"2024","journal-title":"Mult Scler"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1481","article-title":"Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome","volume":"82","author":"Fissolo","year":"2025","journal-title":"JAMA Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1509927","article-title":"EBV-specific T-cell immunity: relevance for multiple sclerosis","volume":"15","author":"Behrens","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00281-8","article-title":"Radiologically isolated syndrome","volume":"22","author":"Lebrun-Frenay","year":"2023","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200439","article-title":"CD40 drives central nervous system autoimmune disease by inducing complementary effector programs via B cells and dendritic cells","volume":"209","author":"Lu","year":"2022","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade6949","article-title":"Switching off autoimmunity","volume":"385","author":"Laman","year":"2024","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1038\/s41467-023-40621-2","article-title":"An integrated proteome and transcriptome of B cell maturation defines poised activation states of transitional and mature B cells","volume":"14","author":"Salerno","year":"2023","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00636","article-title":"B cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation","volume":"6","author":"Michel","year":"2015","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1212\/NXI.0000000000000431","article-title":"Proinflammatory B-cell profile in the early phases of MS predicts an active disease","volume":"5","author":"Guerrier","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111920118","article-title":"Specific hypomethylation programs underpin B cell activation in early multiple sclerosis","volume":"118","author":"Ma","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1212\/NXI.0000000000000272","article-title":"Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression","volume":"3","author":"Varrin-Doyer","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:52Z","timestamp":1764566212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2025.1680233"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1680233","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1680233"}}